SQA Regulatory Submissions and Compliance 3

Question 1

What is the role of a 'Monitoring Authority' in the OECD GLP framework?

Accepted Answer

A national authority responsible for inspecting test facilities to verify GLP compliance within that country

Answer

An OECD secretariat body that oversees global GLP enforcement

Answer

A sponsor-appointed body that monitors study conduct

Answer

An independent scientific panel that reviews GLP study data

Question 2

Which section of an NDA requires a summary of all GLP nonclinical pharmacology and toxicology studies?

Accepted Answer

Module 4: Nonclinical Study Reports (CTD format)

Answer

Module 1: Administrative Information

Answer

Module 5: Clinical Study Reports

Answer

Module 2.4: Nonclinical Overview

Question 3

What does a 'Data Audit' by a regulatory agency such as the FDA typically involve during a GLP inspection?

Accepted Answer

Comparing raw data to reported results in the final study report to verify accuracy and completeness

Answer

Testing the sponsor's data management software for security vulnerabilities

Answer

Reviewing the statistical analysis plan only

Answer

Conducting interviews with study personnel without reviewing records

Question 4

Under US GLP regulations, which agency has GLP oversight authority for pesticide studies submitted under FIFRA?

Accepted Answer

U.S. Environmental Protection Agency (EPA)

Answer

U.S. Food and Drug Administration (FDA)

Answer

U.S. Department of Agriculture (USDA)

Answer

National Institutes of Health (NIH)

Question 5

What is the purpose of a 'Compliance Status Letter' issued by an OECD Monitoring Authority to a GLP test facility?

Accepted Answer

To certify that the test facility has been inspected and found to operate in compliance with GLP Principles

Answer

To grant the facility permission to begin a new study

Answer

To list all nonconformances found during the inspection

Answer

To authorize the facility to conduct studies in other OECD countries

Question 6

Which regulatory pathway allows a sponsor to request FDA agreement on the acceptability of a nonclinical testing program before studies are conducted?

Accepted Answer

Pre-IND meeting with FDA to discuss the nonclinical development plan

Answer

GRAS petition submission

Answer

510(k) pre-submission meeting

Answer

NDA Type A meeting